Literature DB >> 5009623

Alteration of subcutaneous tissue in systemic scleroderma.

R Fleischmajer, V Damiano, A Nedwich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5009623

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  21 in total

1.  Hepatocyte giant mitochondria: an almost constant lesion in systemic scleroderma.

Authors:  G Feldmann; M Maurice; J M Husson; J N Fiessinger; J P Camilleri; J P Benhamou; E Housset
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-06-23

Review 2.  The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis.

Authors:  Yoshihide Asano; Andreea M Bujor; Maria Trojanowska
Journal:  J Dermatol Sci       Date:  2010-07-03       Impact factor: 4.563

Review 3.  Systemic sclerosis in 2016: Dermal white adipose tissue implicated in SSc pathogenesis.

Authors:  John Varga; Roberta G Marangoni
Journal:  Nat Rev Rheumatol       Date:  2017-01-12       Impact factor: 20.543

4.  Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast.

Authors:  E C LeRoy
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

5.  Minimal scleroderma with extensive calcinosis cutis.

Authors:  S F Rabens; M Bauer
Journal:  Calif Med       Date:  1973-05

6.  Alterations of collagen in lichen amyloidosus.

Authors:  D Tsambaos; R Bolling
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

7.  Collagenase in scleroderma.

Authors:  A H Brady
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

8.  Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.

Authors:  M F Martin; P M Dowd; E F Ring; E D Cooke; P A Dieppe; J D Kirby
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

9.  Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).

Authors:  H Kondo; B S Rabin; G P Rodnan
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

10.  PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis.

Authors:  Jun Wei; Asish K Ghosh; Jennifer L Sargent; Kazuhiro Komura; Minghua Wu; Qi-Quan Huang; Manu Jain; Michael L Whitfield; Carol Feghali-Bostwick; John Varga
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.